99 related articles for article (PubMed ID: 927378)
1. [Effect of the dose of Leishmania tropica major culture on antibody formation in mice with cutaneous leishmaniasis].
Dobrzhanskaia RS
Med Parazitol (Mosk); 1977; 46(4):454-61. PubMed ID: 927378
[No Abstract] [Full Text] [Related]
2. [Characteristics of formation of humoral antibodies in albino mice in experimental infection with Leishmania tropica major and Leishmania tropica minor].
Dobrzhanskaia RS
Med Parazitol (Mosk); 1977; 46(2):199-204. PubMed ID: 412046
[No Abstract] [Full Text] [Related]
3. Killing of Leishmania tropica amastigotes by factors in normal human serum.
Hoover DL; Berger M; Nacy CA; Hockmeyer WT; Meltzer MS
J Immunol; 1984 Feb; 132(2):893-7. PubMed ID: 6690622
[TBL] [Abstract][Full Text] [Related]
4. Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica.
Preston PM; Carter RL; Leuchars E; Davies AJ; Dumonde DC
Clin Exp Immunol; 1972 Feb; 10(2):337-57. PubMed ID: 4558410
[TBL] [Abstract][Full Text] [Related]
5. [Dynamics of antibody production in white mice experimentally infected with cutaneous leishmaniasis].
Dobrzhanskaia RS; Ladyshkina BG; Permiakova EA
Med Parazitol (Mosk); 1976; 45(4):415-22. PubMed ID: 1023031
[No Abstract] [Full Text] [Related]
6. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
Titus RG; Lima GC; Engers HD; Louis JA
J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
[TBL] [Abstract][Full Text] [Related]
7. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
Belosevic M; Finbloom DS; Van Der Meide PH; Slayter MV; Nacy CA
J Immunol; 1989 Jul; 143(1):266-74. PubMed ID: 2499629
[TBL] [Abstract][Full Text] [Related]
8. The cellular and humoral immune response in subjects vaccinated against cutaneous leishmaniasis using Leishmania tropica major promastigotes.
Green MS; Kark JD; Greenblatt CL; Londner MV; Frankenburg S; Jacobson RL
Parasite Immunol; 1983 Jul; 5(4):337-44. PubMed ID: 6353318
[TBL] [Abstract][Full Text] [Related]
9. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to Leishmania mexicana in African white-tailed rats (Mystromys albicaudatus).
Sayles PC; Hunter KW; Stafford EE; Hendricks LD
J Parasitol; 1981 Aug; 67(4):585-6. PubMed ID: 7264843
[No Abstract] [Full Text] [Related]
12. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes.
Howard JG; Liew FY; Hale C; Nicklin S
J Immunol; 1984 Jan; 132(1):450-5. PubMed ID: 6197456
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
Liew FY; Singleton A; Cillari E; Howard JG
J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
[TBL] [Abstract][Full Text] [Related]
14. Enhanced susceptibility of thymectomized mice to infection with Leishmania tropica.
Preston PM; Tsega E; Dumonde DC
Trans R Soc Trop Med Hyg; 1971; 65(1):18. PubMed ID: 5092415
[No Abstract] [Full Text] [Related]
15. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
Liew FY; Howard JG; Hale C
J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
[TBL] [Abstract][Full Text] [Related]
16. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
Scott P; Pearce E; Natovitz P; Sher A
J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
[TBL] [Abstract][Full Text] [Related]
18. [On the presence of soluble antigen in Leishmania tropica major (preliminary report)].
Sergiev VP; Shuĭkina EE
Med Parazitol (Mosk); 1969; 38(2):208-12. PubMed ID: 5785717
[No Abstract] [Full Text] [Related]
19. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.
Titus RG; Kelso A; Louis JA
Clin Exp Immunol; 1984 Jan; 55(1):157-65. PubMed ID: 6198115
[TBL] [Abstract][Full Text] [Related]
20. In vivo protection against Leishmania mexicana mediated by monoclonal antibodies.
Anderson S; David JR; McMahon-Pratt D
J Immunol; 1983 Oct; 131(4):1616-8. PubMed ID: 6619540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
